181 related articles for article (PubMed ID: 37924385)
1. P25/CDK5-mediated Tau Hyperphosphorylation in Both Ipsilateral and Contralateral Cerebra Contributes to Cognitive Deficits in Post-stroke Mice.
Yu J; Zhao Y; Gong XK; Liang Z; Zhao YN; Li X; Chen YJ; Yang YH; Wu MJ; Wang XC; Shu XJ; Bao J
Curr Med Sci; 2023 Dec; 43(6):1084-1095. PubMed ID: 37924385
[TBL] [Abstract][Full Text] [Related]
2. Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing.
Wen Y; Planel E; Herman M; Figueroa HY; Wang L; Liu L; Lau LF; Yu WH; Duff KE
J Neurosci; 2008 Mar; 28(10):2624-32. PubMed ID: 18322105
[TBL] [Abstract][Full Text] [Related]
3. Activation of Cdk5/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves microRNA-195 down-regulation.
Sun LH; Ban T; Liu CD; Chen QX; Wang X; Yan ML; Hu XL; Su XL; Bao YN; Sun LL; Zhao LJ; Pei SC; Jiang XM; Zong DK; Ai J
J Neurochem; 2015 Sep; 134(6):1139-51. PubMed ID: 26118667
[TBL] [Abstract][Full Text] [Related]
4. Dendritic distribution of CDK5 mRNA and p35 mRNA, and a glutamate-responsive increase of CDK5/p25 complex contribute to tau hyperphosphorylation.
Tanaka T; Ohashi S; Takashima A; Kobayashi S
Biochim Biophys Acta Gen Subj; 2022 Jul; 1866(7):130135. PubMed ID: 35358667
[TBL] [Abstract][Full Text] [Related]
5. Roscovitine, a CDK5 Inhibitor, Alleviates Sevoflurane-Induced Cognitive Dysfunction via Regulation Tau/GSK3β and ERK/PPARγ/CREB Signaling.
Liu J; Yang J; Xu Y; Guo G; Cai L; Wu H; Zhao Y; Zhang X
Cell Physiol Biochem; 2017; 44(2):423-435. PubMed ID: 29141245
[TBL] [Abstract][Full Text] [Related]
6. Perinatal exposure to lead (Pb) promotes Tau phosphorylation in the rat brain in a GSK-3β and CDK5 dependent manner: Relevance to neurological disorders.
Gąssowska M; Baranowska-Bosiacka I; Moczydłowska J; Tarnowski M; Pilutin A; Gutowska I; Strużyńska L; Chlubek D; Adamczyk A
Toxicology; 2016 Mar; 347-349():17-28. PubMed ID: 27012722
[TBL] [Abstract][Full Text] [Related]
7. Sulforaphene, a CDK5 Inhibitor, attenuates cognitive deficits in a transgenic mouse model of Alzheimer's disease via reducing Aβ Deposition, tau hyperphosphorylation and synaptic dysfunction.
Yang W; Xu QQ; Yuan Q; Xian YF; Lin ZX
Int Immunopharmacol; 2023 Jan; 114():109504. PubMed ID: 36508924
[TBL] [Abstract][Full Text] [Related]
8. Rose Bengal inhibits β-amyloid oligomers-induced tau hyperphosphorylation via acting on Akt and CDK5 kinases.
Mou CY; Xie YF; Wei JX; Wang QY; Le JY; Bao YJ; Zhang PP; Mao YC; Huang XH; Pan HB; Naman CB; Liu L; Liang HZ; Wu X; Xu J; Cui W
Psychopharmacology (Berl); 2022 Nov; 239(11):3579-3593. PubMed ID: 36221038
[TBL] [Abstract][Full Text] [Related]
9. The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation.
Plattner F; Angelo M; Giese KP
J Biol Chem; 2006 Sep; 281(35):25457-65. PubMed ID: 16803897
[TBL] [Abstract][Full Text] [Related]
10. Long-term exposure to ELF-MF ameliorates cognitive deficits and attenuates tau hyperphosphorylation in 3xTg AD mice.
Hu Y; Lai J; Wan B; Liu X; Zhang Y; Zhang J; Sun D; Ruan G; Liu E; Liu GP; Chen C; Wang DW
Neurotoxicology; 2016 Mar; 53():290-300. PubMed ID: 26945731
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of p25/Cdk5 Attenuates Tauopathy in Mouse and iPSC Models of Frontotemporal Dementia.
Seo J; Kritskiy O; Watson LA; Barker SJ; Dey D; Raja WK; Lin YT; Ko T; Cho S; Penney J; Silva MC; Sheridan SD; Lucente D; Gusella JF; Dickerson BC; Haggarty SJ; Tsai LH
J Neurosci; 2017 Oct; 37(41):9917-9924. PubMed ID: 28912154
[TBL] [Abstract][Full Text] [Related]
12. Potentiation of tau aggregation by cdk5 and GSK3β.
Lee S; Hall GF; Shea TB
J Alzheimers Dis; 2011; 26(2):355-64. PubMed ID: 21677377
[TBL] [Abstract][Full Text] [Related]
13. Tolfenamic acid inhibits GSK-3β and PP2A mediated tau hyperphosphorylation in Alzheimer's disease models.
Zhang H; Wang X; Xu P; Ji X; Chi T; Liu P; Zou L
J Physiol Sci; 2020 Jun; 70(1):29. PubMed ID: 32517647
[TBL] [Abstract][Full Text] [Related]
14. Effects of Single-Dose and Long-Term Ketamine Administration on Tau Phosphorylation-Related Enzymes GSK-3β, CDK5, PP2A, and PP2B in the Mouse Hippocampus.
Li Y; Wen G; Ding R; Ren X; Jing C; Liu L; Yao J; Zhang G; Lu Y; Li B; Wu X
J Mol Neurosci; 2020 Dec; 70(12):2068-2076. PubMed ID: 32705526
[TBL] [Abstract][Full Text] [Related]
15. CDK5 activator protein p25 preferentially binds and activates GSK3β.
Chow HM; Guo D; Zhou JC; Zhang GY; Li HF; Herrup K; Zhang J
Proc Natl Acad Sci U S A; 2014 Nov; 111(45):E4887-95. PubMed ID: 25331900
[TBL] [Abstract][Full Text] [Related]
16. Increased CDK5 expression in HIV encephalitis contributes to neurodegeneration via tau phosphorylation and is reversed with Roscovitine.
Patrick C; Crews L; Desplats P; Dumaop W; Rockenstein E; Achim CL; Everall IP; Masliah E
Am J Pathol; 2011 Apr; 178(4):1646-61. PubMed ID: 21435449
[TBL] [Abstract][Full Text] [Related]
17. AAV9-Mediated Cdk5 Inhibitory Peptide Reduces Hyperphosphorylated Tau and Inflammation and Ameliorates Behavioral Changes Caused by Overexpression of p25 in the Brain.
Xu M; Huang Y; Song P; Huang Y; Huang W; Zhang HT; Hu Y
J Alzheimers Dis; 2019; 70(2):573-585. PubMed ID: 31256130
[TBL] [Abstract][Full Text] [Related]
18. Effects of cyclin-dependent kinase-5 activity on apoptosis and tau phosphorylation in immortalized mouse brain cortical cells.
Shelton SB; Krishnamurthy P; Johnson GV
J Neurosci Res; 2004 Apr; 76(1):110-20. PubMed ID: 15048935
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cyclin-dependent kinase 5 but not of glycogen synthase kinase 3-β prevents neurite retraction and tau hyperphosphorylation caused by secretable products of human T-cell leukemia virus type I-infected lymphocytes.
Maldonado H; Ramírez E; Utreras E; Pando ME; Kettlun AM; Chiong M; Kulkarni AB; Collados L; Puente J; Cartier L; Valenzuela MA
J Neurosci Res; 2011 Sep; 89(9):1489-98. PubMed ID: 21671254
[TBL] [Abstract][Full Text] [Related]
20. Cleavage of the cyclin-dependent kinase 5 activator p35 to p25 does not induce tau hyperphosphorylation.
Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T
Biochem Biophys Res Commun; 2002 Nov; 298(5):693-8. PubMed ID: 12419309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
